China Sxt Pharmaceuticals, Inc. (SXTC)
1.39
+0.03
(+2.21%)
USD |
NASDAQ |
Dec 12, 16:00
1.39
0.00 (0.00%)
After-Hours: 20:00
China Sxt Pharmaceuticals Enterprise Value: 157.53M for Dec. 11, 2025
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Sinovac Biotech Ltd. | -- |
| China Pharma Holdings, Inc. | 8.166M |
| CASI Pharmaceuticals, Inc. | 33.38M |
| Zai Lab Ltd. | 1.376B |
| Adagene, Inc. | 170.38M |
Enterprise Value Related Metrics
| Earnings Yield | -156.0% |
| Normalized Earnings Yield | -152.35 |